Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APELLIS PHARMACEUTICALS, INC.

(APLS)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
68.30 USD   +4.42%
09/30Aao 2022 : Treatment of Geographic Atrophy Secondary to AMD with Pegcetacoplan: Two-Year Outcomes from the Randomized Phase 3 OAKS and DERBY Trials
PU
09/30Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
GL
09/30Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 5 day viewTransaction History
Quotes 5-day view   Delayed Quote. Delayed Nasdaq - 30/09 16:00:00
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
59.3(c) 61.76(c) 63(c) 65.41(c) 68.3(c) Last
+1.68% +4.15% +2.01% +3.83% +4.42% Change
842 286 1 036 388 801 061 2 368 756 2 101 584 Volume
58.25 60.06 62.49 62.37 64.99 Open
62.43 62.81 63.72 68.13 69.89 High
58.14 59.76 61.43 59.96 64.99 Low
Performance
1 day 4.42%
5 days 17.11%
1 week 17.11%
Current month 0.00%
1 month 7.42%
3 months 50.34%
6 months 24.23%
Current year 44.46%
1 year 103.3%
3 years 209.0%
Volumes Nasdaq
Daily volume 2 101 584
Estimated daily volume 2 101 584
Avg. Volume 20 sessions 1 670 179
Daily volume ratio 1.26
Avg. Volume 20 sessions USD 114 073 229.12
Capital turnover ratio 0
Rotation flottant moyenne 0
Record volume 1 30 877 960
Record volume 2 17 290 340
Record volume 3 7 282 837
Basic data
Number of securities 109 865 305
Capitalization USD 7 186 289 600
Free-Float 84.5%
Free-Float capitalization USD 6 340 055 960
Highs and lowsPrice 
1 week 58.14
69.89
1 month 56.02
70.00
Current year 33.32
70.00
1 year 30.17
70.00
3 years 16.85
73.00
5 years 11.45
73.00
10 years 11.45
73.00
Indicators
Moving average 5 days (MMA5) 63.55
Moving average 20 days (MMA20) 63.50
Moving average 50 days (MMA50) 61.96
Moving average 100 days (MMA100) 53.17
Price spread / (MMA5) -6.95%
Price spread / (MMA20) -7.02%
Price spread / (MMA50) -9.28%
Price spread / (MMA100) -22.15%
RSI 9 days 58.88
RSI 14 days 56.09
Sector comparison
Change5d. change1st Jan change 1-year change3-years changeCapi. (M$)
APELLIS PHARMACEUTICALS, INC.4.42%17.11%44.46%103.33%209.05%7 504
CSL LIMITED-0.60%2.47%-1.96%-1.33%19.56%88 546
SAMSUNG BIOLOGICS CO.,LTD.-0.74%6.46%-10.63%-7.77%149.85%39 998
BIOGEN INC.1.03%35.00%11.29%-5.97%17.52%38 745
WUXI BIOLOGICS (CAYMAN) INC.-0.63%2.16%-48.78%-62.53%77.75%25 758
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-0.94%4.90%-30.63%-45.64%82.15%19 438
BIOMARIN PHARMACEUTICAL INC.-0.34%-0.08%-4.05%9.86%30.90%15 723
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.-1.90%3.39%-25.11%-25.28%--.--%14 570
UCB0.00%2.42%-29.13%-26.71%7.89%13 248
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED-0.76%1.64%-15.65%-29.50%--.--%8 859
WALVAX BIOTECHNOLOGY CO., LTD.0.49%3.63%-33.99%-41.28%37.46%8 369
CELLTRION HEALTHCARE CO., LTD.1.80%7.45%-15.46%-33.25%35.16%7 323
SWEDISH ORPHAN BIOVITRUM AB (PUBL)0.89%4.51%16.48%-9.03%40.05%5 747
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.-0.60%7.31%-56.98%-36.99%-13.82%5 617
GRIFOLS, S.A.0.54%-11.40%-47.37%-58.08%-66.67%5 301
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.0.19%2.90%-21.85%-21.85%-31.67%5 050
 Average-0.10%4.85%-20.92%-26.36%29.70%
 Weighted average by Cap.-0.31%7.23%-13.07%-17.38%45.91%
Historical data 
DateOpenHighLowEnd-of-dayVolume
09-30-202264.990069.890064.990068.30002 101 584
09-29-202262.370068.130059.960065.41002 368 756
09-28-202262.490063.720061.430063.0000801 061
09-27-202260.060062.810059.760061.76001 036 388
09-26-202258.250062.430058.140059.3000842 286
09-23-202260.780061.165056.020058.32001 693 932
09-22-202261.960062.290059.780061.09001 033 444
Daily chart APELLIS PHARMACEUTICALS, INC.
Duration : Period :
Apellis Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Monthly variations
annual change
2022 44.46%
2021 -17.34%
2020 86.81%
2019 132.2%
2018 -39.22%
2017 54.67%